Model
Edge
Moonlake Immunotherapeutics
MLTX
Filing Type
4
Filing Date
7/19/2026
Updated
7/20/26, 4:07 AM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership